Boston Scientific (NYSE:BSX) today reported first-quarter financial results that came in ahead of the Wall Street forecast. Original Image Link Source:www.massdevice.com
On April 22, 2026, investors weigh a rare combo of earnings strength and softer long-term targets reshaping this medtech leader’s outlook. Original Image Link Source:finance.yahoo.com
Made Scientific, Inc., a U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Regenicin, Inc., a biotechnology company specializing in the development and ... Original Image Link Source:finance.yahoo.com
Core Scientific (NASDAQ: $CORZ) is planning to raise $3.3 billion U.S. through a junk bond sale as it pivots toward artificial intelligence (A.I.) data centres. The bond sale comes after Core ... Original Image Link Source:finance.yahoo.com
April 22 (Reuters) - Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, overshadowing a first-quarter earnings and revenue beat, while its shares were little changed ... Original Image Link Source:www.msn.com